Acute hemorrhage from esophageal varices is a medical emergency; despi
te early diagnosis and treatment the associated hospital mortality rem
ains high. The clinical research summarized in this paper shows that o
ctreotide has a beneficial effect on portal hemodynamics in cirrhotic
patients. In randomized controlled trials octreotide has been effectiv
e in halting initial hemorrhage and in preventing reoccurrence of blee
ding. Somatostatin and octreotide appear to be equivalent in terms of
therapeutic efficacy but octreotide is the less expensive option. For
suspected variceal bleeding an octreotide infusion should be initiated
immediately. To prevent further bleeding the drug should be continued
for two to five days after endoscopic variceal ligation.